<qa>  What is the STUDY TO EVALUATE SEROQUEL AS MONO-MULTICENTER, OPEN-LABEL, RANDOMISED, HALOPERIDOL-CONTROLLED STUDY TO EVALUATE SEROQUEL AS MONO-THERAPY IN THE TREATMENT OF AGITATED SYMPTOMS IN THE PATIENTS WITH ACUTE EPISODE OF SCHIZOPHRENIA: 